Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Dartmouth, Alcon, and More

Premium

Title: Determinants of Sensitivity to Chemotherapeutic Agents

Patent Number: 8,673,869

Filed: Dec. 14, 2005

Lead Inventor: Anna De Fazio, University of Sydney


Title: Method of Modulation of Expression of Epidermal Growth Factor Receptor Involving miRNA

Patent Number: 8,673,872

Filed: Aug. 28, 2007

Lead Inventor: Peter Leedman, University of Western Australia


Title: RNAi-mediated Inhibition of Phosphodiesterase Type 4 for Treatment of cAMP-related Ocular Conditions

Patent Number: 8,673,873

Filed: Oct. 16, 2009

Lead Inventor: John Yanni, Alcon


Title: Methods for Treating Pancreatic Cancer

Patent Number: 8,673,874

Filed: Dec. 5, 2011

Inventor: Murray Korc, Dartmouth College


Title: Method for Treating Atherosclerosis

Patent Number: 8,673,875

Filed: Dec. 11, 2012

Lead Inventor: Suh-Hang Juo, Kaohsiung Medical University

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.